-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LJXdZUSDKWvYC5L39NOnv/bOJ96lQo7OehXuay3ulHmRkzlWhMIHdPUnOqZdhbhT 8SEIORGLVaUAd3977Iavow== 0001104659-10-022130.txt : 20100427 0001104659-10-022130.hdr.sgml : 20100427 20100427163627 ACCESSION NUMBER: 0001104659-10-022130 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20100426 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100427 DATE AS OF CHANGE: 20100427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 10773840 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 8-K 1 a10-8858_18k.htm 8-K

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

CURRENT REPORT

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act

 

Date of Report (Date of Earliest Event Reported): April 26, 2010

 

Hanger Orthopedic Group, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

1-10670

 

84-0904275

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

Two Bethesda Metro Center, Suite 1200
Bethesda, Maryland 20814

 (Address of principal executive offices (zip code))

 

301-986-0701

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a - 12)

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13d-4(c))

 

 

 



 

Item 2.02 Results of Operations and Financial Condition

 

On April 26, 2010, the Registrant issued a press release announcing its financial results for the quarter ended March 31, 2010. A copy of the Registrant’s press release is furnished herewith as Exhibit 99 to this Current Report.

 

Item 9.01:       Financial Statements and Exhibits

 

(d)

 

Exhibits.

 

 

 

 

 

99            Press Release Issued by the Registrant on April 26, 2010

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

HANGER ORTHOPEDIC GROUP, INC.

 

 

 

 

 

 

 

 

By:

/s/George E. McHenry

 

 

 

George E. McHenry

 

 

 

Chief Financial Officer

 

 

 

Dated: April 26, 2010

 

2


EX-99 2 a10-8858_1ex99.htm EX-99

Exhibit 99

 

Contacts:

Thomas F. Kirk

(301) 986-0701

 

George E. McHenry

(301) 986-0701

 

Thomas C. Hofmeister

(301) 986-0701

 

News Release

 

HANGER ORTHOPEDIC GROUP, INC. REPORTS $0.16 EPS ON 16% INCREASE IN PROFORMA NET INCOME FOR THE FIRST QUARTER 2010.

 

BETHESDA, MARYLAND, April 26, 2010 — Hanger Orthopedic Group, Inc. (NYSE:HGR) announced net sales of $178.3 million for the quarter ended March 31, 2010, an increase of $9.2 million, or 5.4%, from $169.1 million in the prior year.  Earnings per share, excluding the costs related to the relocation of the Company’s corporate headquarters, for the first quarter of 2010 were $0.16 per diluted share compared to $0.14 per diluted share for the same period in 2009.  Reported diluted earnings per share, including the costs of relocating the corporate headquarters, were $0.12 for the first quarter of 2010.

 

The $9.2 million, or 5.4%, sales increase for the quarter ended March 31, 2010 was primarily the result of a $5.4 million, or 3.6%, increase in same-center sales in the patient care segment, a $0.9 million, or 4.3%, increase in sales from the Company’s distribution segment and a $2.9 million increase principally related to sales from acquired entities. Income from operations for the quarter ended March 31, 2010 was $14.2 million compared to $15.1 million in the prior year.  Excluding the $2.1 million of costs related to the relocation of the corporate office, income from operations increased 7.5% to $16.3 million due to the growth in sales and continued expense management efforts. Proforma income from operations as a percentage of sales improved 20 basis points to 9.1% in 2010 compared to 8.9% in 2009.

 

The Company used $12.1 million in cash in the first quarter of 2010 which was $8.4 million more than the $3.7 million used in 2009 to fund normal working capital needs.  The Company had total liquidity of $127.6 million, comprised of $64.1 million of cash and $63.5 million available under its revolving credit facility at March 31, 2010.

 



 

“I am pleased that we opened 2010 with a very positive fashion.” commented Thomas F. Kirk, President and Chief Executive Officer of Hanger Orthopedic Group.  Mr. Kirk added, “Our patient care segment performed well posting a 3.6% same store increase and we continue to see positive results from our other growth initiatives.   The increased revenue combined with our expense management generated 7.5% increase in operating income and a 20 basis point improvement in operating margin.   I want to thank our employees for their hard work and their continued dedication to our patients’ and customers’ needs.”

 

For 2010, the Company expects full year revenues to be between $815 million and $825 million and diluted EPS, excluding cost related to the corporate relocation, in the range of $1.27 to $1.29.  As announced in February, the Company is in the process of relocating its corporate headquarters from Bethesda, Maryland to Austin, Texas and anticipates the move will be substantially completed by the end of the third quarter of 2010.  The cost of this move is reported as a separate component of income from operations.  In connection with the move the Company reported $2.1 million of severance and relocation cost for the three months ended March 31, 2010.     The Company anticipates incurring approximately $8.0 million to $10.0 million of additional severance and relocation cost through the third quarter of 2010, as well as lease exit cost of approximately $3.0 million to $5.0 million.  Once complete, the Company anticipates that the move will result in a reduction of operating expenses of approximately $2.5 million to $3.5 million annually.

 

Hanger Orthopedic Group, Inc., headquartered in Bethesda, Maryland, is the world’s premier provider of orthotic and prosthetic patient care services. Hanger is the market leader in the United States, owning and operating 678 patient care centers in 45 states and the District of Columbia, with over 3,700 employees, including 1,110 practitioners, as of March 31, 2010.  Hanger is organized into four units. The two key operating units are patient care, which consists of nationwide orthotic and prosthetic practice centers, and distribution, which consists of distribution centers managing the supply chain of orthotic and prosthetic componentry to Hanger and third party patient care centers. The third is Linkia, which is the first and only provider network management company for the orthotics and prosthetics industry. The fourth unit, Innovative Neurotronics, introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers worldwide. For more information on Innovative Neurotronics, Inc. or the WalkAide®, visit http://www.ininc.us. For more information on Hanger, visit http://www.hanger.com.

 


This document contains forward-looking statements relating to the Company’s results of operations.  The United States Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for certain forward-

 



 

looking statements.  Statements relating to future results of operations in this document reflect the current views of management.  However, various risks, uncertainties and contingencies could cause actual results or performance to differ materially from those expressed in, or implied by, these statements, including the Company’s ability to enter into and derive benefits from managed care contracts, the demand for the Company’s orthotic and prosthetic services and products and the other factors identified in the Company’s periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934.  The Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

 


 

-tables to follow-

 



 

Hanger Orthopedic Group, Inc

(Dollars in thousands, except for share and per share amounts)

(Unaudited)

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2010

 

2009

 

Income Statement:

 

 

 

 

 

Net sales

 

$

178,316

 

$

169,146

 

Cost of goods sold - materials

 

53,650

 

51,049

 

Personnel costs

 

68,769

 

64,059

 

Other operating expenses

 

35,315

 

34,451

 

Relocation expenses

 

2,059

 

 

Depreciation and amortization

 

4,311

 

4,456

 

Income from operations

 

14,212

 

15,131

 

Interest expense

 

7,542

 

7,607

 

Income before taxes

 

6,670

 

7,524

 

Provision for income taxes

 

2,668

 

3,009

 

Net income

 

$

4,002

 

$

4,515

 

 

 

 

 

 

 

Basic Per Common Share Data:

 

 

 

 

 

Net income

 

$

0.13

 

$

0.15

 

Shares used to compute basic per common share amounts

 

31,881,750

 

30,926,725

 

 

 

 

 

 

 

Diluted Per Common Share Data:

 

 

 

 

 

Net income

 

$

0.12

 

$

0.14

 

Shares used to compute diluted per common share amounts

 

32,926,033

 

31,955,851

 

 

 

 

 

 

 

Pro-forma:

 

 

 

 

 

Net income

 

4,002

 

4,515

 

Relocation expenses, net of tax

 

1,235

 

 

Pro-forma net income

 

$

5,237

 

$

4,515

 

 

 

 

 

 

 

Diluted Per Share Data:

 

 

 

 

 

Pro-forma net income per diluted common share

 

$

0.16

 

$

0.14

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2010

 

2009

 

Income Statement as a % of Net Sales:

 

 

 

 

 

Net sales

 

100.0

%

100.0

%

Cost of goods sold - materials

 

30.1

%

30.2

%

Personnel costs

 

38.6

%

37.9

%

Other operating expenses

 

19.8

%

20.4

%

Relocation expenses

 

1.2

%

0.0

%

Depreciation and amortization

 

2.4

%

2.6

%

Income from operations

 

7.9

%

8.9

%

Interest expense

 

4.2

%

4.5

%

Income before taxes

 

3.7

%

4.4

%

Provision for income taxes

 

1.5

%

1.8

%

Net income

 

2.2

%

2.6

%

 



 

Hanger Orthopedic Group, Inc

(Dollars in thousands, except for share and per share amounts)

(Unaudited)

 

 

 

Three Months Ended

 

 

 

March 31,

 

Cash Flow Data:

 

2010

 

2009

 

 

 

 

 

 

 

Cash flow used in operations

 

$

(12,073

)

$

(3,716

)

Capital expenditures

 

$

7,914

 

$

2,827

 

Decrease in cash

 

$

(20,492

)

$

(6,480

)

 

Balance Sheet Data:

 

Mar. 31, 2010

 

Dec. 31, 2009

 

Cash and cash equivalents

 

$

64,066

 

$

84,558

 

Days Sales Outstanding (DSO’s)

 

46

 

50

 

Working Capital

 

$

223,242

 

$

216,664

 

Total Debt

 

$

408,762

 

$

410,472

 

Shareholders’ Equity

 

$

324,260

 

$

315,893

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

Percentage of net sales from:

 

2010

 

2009

 

Patient-care services

 

87.5

%

87.4

%

Distribution

 

12.2

%

12.4

%

 

 

 

 

 

 

Payor mix:

 

 

 

 

 

Commercial and other

 

59.4

%

58.6

%

Medicare

 

28.3

%

30.3

%

Medicaid

 

6.8

%

5.9

%

VA

 

5.5

%

5.2

%

 

 

 

Three Months Ended

 

 

 

March 31,

 

Statistical Data:

 

2010

 

2009

 

Patient-care centers

 

678

 

675

 

Number of practitioners

 

1,110

 

1,083

 

Number of states (including D.C.)

 

46

 

46

 

 


GRAPHIC 3 g88581mmi001.gif GRAPHIC begin 644 g88581mmi001.gif M1TE&.#=AGP)P`'<``"'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"P` M````GP)P`(<````%!047%Q'AX*"@H9&1D#`P,("`@?'Q\2$A(1$1$6%A85%14+"PL3$Q,/ M#P\4%!0;&QL0$!`8&!@Q,3$]/3T^/CXW-S7EY.3DY*2DI65E945%1& M1D9<7%Q5555"0D):6EI)24E965E-34U=75U#0T-04%!34U-$1$1%145145%? M7U]/3T];6UM'1T=!04%+2TM,3$Q(2$A`0$!W=W=C8V-J:FIO;V]F9F9H:&AQ M<7%L;&Q@8&!D9&1X>'AG9V=\?'QS7EN;FYI:6EU=75B8F)[>WM] M?7UP<'!V=G9RGI_?W^?GY^>GIZ:FIJ0D)"3 MDY.1D9&&AH:"@H*+BXN6EI:-C8V4E)2/CX^%A86,C(R'AX>(B(B9F9F5E96;FYN`@(".CHZ!@8&=G9V8F)BDI*2@H*"V MMK:HJ*BBHJ*ZNKJEI:6NKJZLK*RGIZ>IJ:FCHZ.SL[.QL;&_O[^AH:&JJJJ] MO;VXN+BRLK*TM+2UM;6[N[N^OKZMK:V\O+RYN;FFIJ:PL+"OKZ^WM[>KJZO. MSL[7U]?,S,S-SWM[#P\/+ MR\O'Q\?;V]O*RLK`P,#)RG@X.#BXN+T]/3M[>WJZNKDY.3KZ^OFYN;E MY>7CX^/AX>'___\(_P#_"1Q(L*#!@P@3*ES(L*'#AQ`C2IQ(L:+%BQ@S:MS( ML:/'CR!#9@073J3)DRA3JES)/_B`2]F3-Z_>,22"817N9ZRK067,1-HK][`>=+_8?\7 M&*[VPJWQ8H->S[X]S%(`XLL'P;E@LP#RY3MC!@1,F&:#B#$&(8$$$8(IA9SR MCR&G"$,&&&6`(X800Z"2B@A$J'+("$68HDDPVN=$J^<6W MQ%,%L1(E``+@L\@;_S`22B'1N`/'/Z,T\H\CIJP3!RAR2/,/$\J\D0\Q33S2 M"CSCS*&*/&M,8P0U3KAB3AKZ#+3/$.7P\THK:/SSABACD"+/$\*`H4\\)`0# MB3F1A$&0),0P4<(Z<\`"1376B)&7DZRVZFI"=%S_"09"@5QIPC^OQ/)/-9-` M(4049@)R!I$G2(%"*%,4R@@L233AQB"KI#"%+'#,\D\DE*`!#1//"#3>,%-< M0PLUM:A`QPC8%*%<(]B0$0PZ5&1C!"!.5$)0':^(T<8B=KQ2A3VO!BSPJT9< M>0=">%P)Q3^%"/)/+8+(45H>_P"BQS^6V&$-%*FP$M0\*5B`A$2!Z/E)-+/^8\@@XUMOQ3"N^Z/!-/)&R0\L\NROW#C1AP M\$(+&'"PW$L_^*QQA"D%U:)%$W7PT\H_T^!RC1(K0#+.*48$88H]B8!CT"NV M6$4^P"$$;V###6?H13E(`3#;.?"!A:'&`:)4@'<2^A`$'28: MR%;,<8^!D(,=`O'?0LK1%GC@0R#RF!T$9TA#N.#B2@FPF4&2H8`H+8`?1@E' M"/]K2,0B+F835WH"0H1A`!\"<27@2`U$VC%$(UKQBH$9PY7V\(]UP$,<8`3C M)`80)1`TD"#0V(01E(`&23A#B@41!SCDJ$)K/*(,;R"%=PKB%('$`QG)``8M MB*&UA.3#&(E(A#=TV!!_+",;^\"B)"(,#\O,`8QP$'YMXP0$:$!\(K``/=XA#'-+0 M+8$4HP\1D$!\!I`"2@PQ'4PX@AZ8$`9#H,,,$9C`!"CP"CA2\IO@#$HX6!"E M`.A""5=*)P`.)I!TV$$^%8"#&B(@'PO(HB!WB-(%`$#_`#+*)P9#(P@H9"`? M#(0!!>G,AD!:0<_XS``+I@3`'(PC$')4(#\L"$*4&,#(<'KTHS7IQ@2BE(%B M\$,:S\@%-80AC%@L(&R<&(@WY+,`#AYCG_&QP#(&(@XA7(D+V0!#E'A!D$#@ M)SX&(*HN)A@?!%#!$EMA10_CXP#IS$$^9A((-)BZ3`"$``WRZ8(,04K6LJ*D M%[S,#P;\<1!Q:"!L1!6(+M)J"((`(3]R&,@Z4A`E&A3C'["(TB(&(HRCQD<+ M`O'&2'L9GGS@-#[LE(-\"A#)?_A"F?FI`3K`88/X-,JLH`UM2`IQI1$4DB#2 M:&)^+.`C@40B/B8XH]WR;D2N(TIL"0<65;``1K6."4N3A(.E9P MI9@*Q!T="$)'P?&$L*U"(._,S\*60X'\'"`W_[A%1.,S!H&L@YSY`<0CHB0! M(.A!#U?(0'YVL`YZX#<^"VC&0.Y1@0=TE-#`%JTN3@P`#R#C(/;@P95(/!W4 MZ!477+@2`88A$)_FYP\"T<:M`:`!07?CT/(1@WW?"P`+[$/*ZL0A.("QV/B$ M8(B5^$,5@TWOCX[#'*OPIWP84-Z")&,#TZ5V0;I!B#7L.9TTB.0XL)"?`<0W MU"<>07WX*A\S1#=*63#'$GR(!2_(:`0<:L(3+`Z(*"6AWBC_WZXXY$'@_)3@ MM#(E0)048-M_X",3*X!`?CPPZOCHX"_VB',OKS&. MRI9/%>:1CA%$Z0@$`6-!+IP?X:;\ZZ#5^)7F@!!!Z#L^*6B@+4`@2FR`6SY* M:,LVR'V#>YAC'G7(\3\T$1\JW&#?3)?/$TKH#X#GAV(*6;%\7@'VQI-5'C&X M$GH/PH:?"H08;Y?/&O[A#UGGAW2U*"X`HM`6.(MGP,X*:5C-7QR)<,,RX:)<8?A.%1LH-\ MQRZ05%P)%`)YQ-F3,,(H1(D5^0AE_PP&8@YP,*,;V]B&!0GBCVT/0!0'\<21 MTY&`_"C@KROI8_+W+YEL(`,B@.71`EDY+1B&0H$.8"@6I!4EHW(0U"!S M^6$`KO`/WQ8E@S`0;Q`E.``PZ>"!3?6&_V`-.B!P?#,1!E>R!51" M$*IP)0_`7/5PA/)1B?^0#E>6'P)V'#V0'Q`@#`(Q"F>'!>60!NG&:E-00OY5 M7'-6$/*@`AZP'1"8'[T5BV7(B=((%N3PB3(A#E5P)1=S$()@*W\Q#EX0)5/0 M1?.5'W@@$,G0;@#0`P%548'\&C#HPFC_)Q M`-TB#\K`50?P"_)0#LL@93E@'.N@`OG1`$XSD#+)*M?PA_EQ3S/_>`174@<$ MH5[R>(Q$$B5"@!TA%A\2P$'4P'P>"0!T(![_L`KMU@`Z4`(3M`.@U@Q*"0`; MT`TSV95-X@H"X`$-,)8-4`''9A#HT`(20)8-@``..!`2-!#I M(`_G\`[[0`[P``_DH`[G$`[\8`_H(`_W0)KHD)JJ^0[J<".J^9JP&9NR*0_K MP!8,88U>F9LR`0[-$`S?X`S`63(',0[\P`W`"9S&4)FA!@54$`5S<`O_H`RC MX`O8X`S8T$#[\`WQ`PK.L'[CL`R_R0VW_X`+<_$/]Q`&=]`(C;`)D/`'E(`';/`&9E`'>*`'>8`'1GJD2(H' M;0`&:E"D29JDAM`()JG>JJGNP`+M9`*U5`*QE`*M\`* MSW`-^S$,T&`-Q?]P#,W@#U!(#\4`A<50#/[@#_60#_4`J<60J>W0#OV0#_W@ M#J'ZJ>VP#^[@#OM@JJR*JJSZJK#ZJJX*J^YP0O?@#K`Z#_?PJO/P#K>J#OC` MJNZ@#\0:#NR@#[BJ#N\P#^T0#^^`#N3@K)X)#ZS9#KO:J^J@#N5@#_.@#NP` M#O8`#NDP#NN`#_%@#^FP#GBQ#D57#N[ZKNZZ#N8`K^/0KO`*%-A1=-XBBKK9 M$.-`B@#P!?]@#_#`#_F0#^T0#M1P<```!Z>X$?;0#?GP#O%P#O=P#^?0#OD0 M#?>0#\'0#=%0#-TPLB2+?L6P#26;LBJ[LBD;#,1`#,>P#,EP#,IP#*7_T`O* MH`W(\`V\(`K4H`S58`RR,`V^``RN8`N@H`BX``NFL`B#4`A0&[51.PB+0!J9 M\+12F[654`F%X`F?,`FA``B5P`B!L`J`L`J@``J:X`F98`I;BPBA\`F?8`A^ MT`>7<`=ND+=V0*1BX`9QP`=\F[>".[B$6[AK<`9N@`=C(`=C@`=9T*`-J@9R M\`>=X`>;@`>76P>'(*20<`AO(`=V@`9FD`=T(`EZL`=54`5K,`=ET`1B,`=; M$`5+\`1=P`5/L`11D+NYNP13H`6XJ[O`&[S!NP1"X+O"NP5`X`16\+NZNP15 M\"O-BP1&L+QSX`7,.[M`&=V`&;@`'9M"YAY#` M"IS`>,`'"^P'#KS`"?P&?^`'8*"C:J`'FX"B4``%9(`&;E`&>!`'9M#!)@P% M83`')[S"+,S">R`&>>`'5X`&=R`'9(`(B#`)CH`)BJ`(F?`(0!S$GX`)FI`( M0%P)F8`(D5`(GY`)BV`(EH`(AC#%5%S%5GS%C<`)DX"CB8`(B2`*JF`*NS`+ MO2`(I3`*J``-V+#&;&P,;,S&T*#&QN`-U$`-T#`,N&D6]R```&!."8%$\5$+ M_7H>3NDM!%$.[$I^Z__P#N\`#K7)#N*P#A=[#YW)#O`PR9A\#N2`R9S\0#JX<#OAP#YL\#ZB\J_K0#L$ZRKJLJ[4\ MRO/`#[J*#_BP#_.0JOS@#M>:JLSJ#OS0S,[\S*KZS,Q`#\_LS-90#]$0#/W` M#]L@#?W`#-1`"[40J-/`#<>`#=I0"^J\SK$0"^O\SO``""_MTF?_ M``>,T`E((@42*EMNL0\C%0#$O63C8-0.X0Z/8`4[4``* M\``^$`:$,`^%7=G2B`[O0`_J@-B6W=F>_=F@'=JB/=JD7=JF_1GUP-.GO=I) M!D*L_=JP'=NR/=NTC7+P8`W7T`_;@'\.40[1D`\BNWX)D0Z0!!'PL`W62*X& M(:Y,_1#IP-FU'=U"(09;,`(1X`4@\`L/(0Z+P`$S_\`%5)`)"!%)N8`!@OP0 M=6`#*7@0\<`&6A"3QU`">/!$!<&O!@$/57H&FX"3TAT9Z+"!$"8.A7`/J<`" MY.`*@S`.9)@.XK""P6$0\H``DI`.6_4^`F$BQ3`$)'$#T)F%!#%'4H0+* M,C0.M@``1C`00P``@C!OFY#'!!$/+1`']7`-<.!U"C$/S-;?@F$.#PM%[$I1 M_P`.^F#?F8$=LS`#X``/3I`'WM`$;#`/6:`+W7"XG=!1]W``V:4-"G!5Y M#JJD#IZP"?0@#MCP"#I,L$\``]36#9UP7.00"\[P",3(XZVB#V-0!#NB2G^@ M!=#]$+;0!4`@:/L`NH3IZ>?-$/B`"9)`V?_@#I80"6>Y4(L0ZW<]"YNMT@@G<`U[L`',4`@P@!'HL,,J<`7_8`Y,P`>V4`4H%`TF4&$,L0Y& M0`J6X`7W(`Y,$`JX0`(E$0]ED`?&L.L"<0E98`A-:0T^0`,TD`%N4M-,,"3_ M<`H=\)8?$0@S`##S<`+7 M(`GY``@A,+`[\`WI(`#,<`D\H-*5<`Y7/?- MWZ&IW`]H\&04^P=&B+F3!M,!ZTF/QK%_([AM,_9.F15YPDZ8>V9B MW[]B.%KUQ)I5:U91/S+^BX-CT!(8[?9Y./5/C96O_^)-(&0P!A!K&[+]D]:N MDHAQ\GRX8A?!'Z(?!DNQ`V:)@*I$.?Y]\_$/U!17#.J=I(:F7!0%IHH=.)4N M`JY_XOB58B'NWY='__(IX/9/3/^1K^/X;+AW<5@V%#C;_7OUY5\>3O_VZ/G7 M:8U!:_^RK-H:7?ITZM6M7\>>77OT+7A3 MH\P_55.FC5@C#PH#1#=:@^D#B`IP.BF5'D9RI@-X_FFB$X,4`:.G<>1H((1U M+H)F`J*\..2?1Q3X@K1^!+!"BD[:*D<-`^9(YR)L!#CGGR#9+$!G4:P^*<<.E@818MO+BJG%@"N0`4-%J@9QPT+ MEE@C'E0XZ(2:!3@1AH!<^F%A!BT8T:<(6DY(I!L/_H##`%Z$6,&1`2[AZ1]S MQE(GD!W_XK$%@$'2"8,#,ZZPIIH*+.GF!#O068<*(K;1`DB#PM'!BF#XP<24 M>Q)8`1(UUJ'DA7?2$,.<(7(0Y90-2$$$$W%J2"1(7W\%-MB3S(E(6&./1399 M94]:9(9,*O%.$!C^,:2(='(HKI<#Y$E%C'^D^.,=%)*8HHJ[3I*EA`3T\:8# M=O[AT"!'T!CGI'**`$"#8O]!)P@J(JE`DW^P&6&`X@)!`!I:#C`&)1X`P"!& M@Z")X)U_BJ"QR2QN^8>0$,J19X<>_^F#-%_)`04360P2!Z=]"OH''$SX@&;8 M63P)Q1-'D#$('$C2T.O\Y!P\W;+EGEG(:V>.-?>[Q8PN![:D#D6?(@"*:?_R)0PU/L.HG M#!+0`"4C6TSX019X-DFC%SOLN(>6+6KYYY`;T(`G&23\V'=9S3?GO'///P?= MV$RJ..D1$?[Y0PAQ3&#C'V5,`(<3,_[I@I)Z')#FGWE`ZBD<"ZS1Y@)\_FFA MM7\4H0.K9>QHY>N>>5%#@'K402(:7@IHYA<(%MRBD9-T$2*5DX`IP.(B(C'H M&B_DZ;B%?]ZA`$@R)@F]_NH"W>X>]B\2)Z.O__^'\XH%#G.,`W_V0V`"%;A` M!C:0.NBP`PWH4:]Q&*(#^RC#"M91"?\>$.,-8!!')[S0CA&(P1Y*`($BXF`W M@[B#$-T(1!+`L8X@9$(;*IB*.>BPA@-&)TZMJ0<.EB$C9[S#!]ZPQQ:F%!UY MB(`6Z+"!,@R2B0C]0QLI8$DDA8PX$8QC%.$8REM&,9;R&(>QP"IZD MPQ!IP`4=]'"-?T1"#I-`1SOR0(90X,$,W7#'&8#0L(OP@PM*.(0_#-*/0^!! M%P9YAQK6,!7IE(,492C%17A!!C\T(A[_8(41[%"(MFSE&V<0@QK\1X9I7$02 MY MJ,XXHL&,BR1#%=NXR#M0`;-_N(,7RSQG0,$CCF,*U*`'1>@Y@Q$%1[S!`\[$ MRB=^81!^:B47*.C0/ZKQ`QQT(#;AL$(>FH!/8CR!#D(87D)5&IUS!'.E+X5I M3,>XBAUDY!+UN,<\RA$.B_UC'>3XARB&`-%^Y*8G\/A"'0SRB&JPPPM/0%T7 M_C$&/8S#"=,9YD6. MN9`R1J,"/#C%NV)1`F.80@;YX,<(:(2%&P"B')J@Q!1&=A(L\*$G_W(X0U$B M9(D'X,,$H_C'):CPUJ]VUK.?72`X2KF=PPK@")=`0ANJ4XY7U*``0#H&%*`` MG7_`PP]N4,UTLB$'-)C"(,"0`QM(\35R**(2"Y*..B!Q"&W68A.-<(0P_B$/ M2D0BFJ)P`B*N>9YCU```06"?%121CA/0(AU:F!T;I/"/9%`@#RO@@5EEY-B+ M[*,&UE@'!^[P#UE<@!X_X,4_*`&#%F5%'$`%;8(5O.!?D2.WX=%'`Q;Q#WZ0 MQAS[:\M;Y3$*8IPA!^98QQ(RX8\7X/,<:/C8=.+A!5`L0P;0&,<7=*$/&%#C M'_M@*'*E8XDV'*,*UW`'$LA@!P;T8AU;:_\$$,21C2.,P0/T-4\]RE&.2P#@ M1E0*4U=$'>)I#!'+XAR<8X(X?D`81 M*4;F@QG,2WOL;\\G>413G'TN(+!8PT8X9S*++^^7# M"&>!`67``Q&9^P<6(&&0=5WW.4^]_.X`P*6F,M&"NO"%KUS!2(S8PC_L$0'ZUB,($#7/.<@!_XU; M#%`:]R@K.:A!#>\<8QXQHX9%>L(,8V#C^,&0AC>P`;-]E(*?_7A$3^F^?>YW MOSKWF``F?&($2/#B!S$J11=2H$BLC.,&R.!'`C@6`T`89!"DZTDY9C%$K%3B M`?L`AQ5`!G#P`4\H!N'Y!R"`LT)B!&P`@,Z``6#Z`8QP(.1F(YP"(,HV)N7RR2#R(8T:(-6&@4'^($$``'MD\-7A,58 ME*DSNPA:W+?H<$5U>*M[,"IUT`=VP`>),2/.DL5BY"5UB"MC5$;J&`=<:`1. M*(1"N$&MV(8TR)UXP@4Y$,:MJ(4_D*Z+2(5.2(9?8`1/F`1;X!U[`81&H"3^ MT@0,"X1)Z*EQ((9KO`A_,,)EU,=A(<9]],>+0`8`0`-NX(,=T*9:_`=:H+`1 MZ(7KN`0.T+&M$(8#B('_W*('`*B!?K@%`F@!1T@""A"?DT`$&+`!5_F'4Z@" M0Q""=Q@'-DB"34""WU@&$[""D^@&'#"9?]3)G=Q)>?B`"?N'"1"Z?Y@&3\"' M>/@$$Q@U/%B%4E"^=^"%45R'6XB%8G&&3SB!!?&'6JBHGL@"`+@*@;,R@V@! MI?H'/E``-SR'55B'<.B`43"'%[A$&""$=+B`1_H!1Y0'/)`JEMF#`T`YGA3, MP33&>\B`*0"%)"@`NV&$-M@#&-@',7@`O7.#$%""'>`'<(`",`"!0S`'/#B$ M)&@E/D"#/?"`9LB&&H`#$&C'DQ`'2&B!=6L&+A`!I4('%G@#@\`'`\@$*LF( M_W*`@6H@APN0M3%P-SQ@@34PA`+[`R*XB$2@A!&8*,*DSNI\PW=P`"E(!2!( M@&>X!QR@`TO8@F#8A1`(("DH!'+0@&2HA@L(@RUX@7NX`3%XAG"P!18X!VVP M`7;@ACS0A;3,"G"PA%RH`A$!@@N0YAP_P`[62@4'`"DR(K&+X@(;)`R/X M!V+8`0"H/X.H`^?\AUM0`W```56PSA-%T>UC!P6("YB(`F+`@&PH!W+`!TTH M`8.0`E2`AP(H!DK0@6!H!VU`!UKH`1L0!D0@@7^`!AZPAWN0!$C``!;J"7-H M!'8@@2C8`W10@N11!PU(GHX``$'H"62X@N&Y!PRH&?\FV`-S"`)?6`0%<,1_ MJ(.^+)<@@``2Z,H4U=,]!:USN($[T`=CP``S6`<16()2J(-F"`49$`5VD$MR M4`!GH(8,L`1=B(1\$`-VX`(]F(8`T`5=X(!A@`,O,!-?``=3P*>+0(",E.N`*# M>(9'*(0'R(.TXM-II5:N8@43B`(I(()->(E<,`$:Z!5_R`$^L(434()'>``\ MP)$(2(%JD(<4D(,D<(5D,X$I\(%?:(4.(((2N(-XF`$C^!]24(%,D(8@"#S`!!J`$O'B"=HN'<3`#(HB$,Y"\:Q"! M'$"VBWB!L*S6E659E5('=6C29`0'!/,IL+D'?9@'=D`P>/BD<8"'>M"^<("' ME.H'=D@'<1@'3U`#Y\$'?3A9W:F'>9"'<`!&>CB^_*.':(`&;K@F?]"%W!J' M:7@B@\B'6BB%JQ44:D#;EF7;MAU!=`"%B'3;N:7;NK7;N\7;O-7;O>7;OO7; MOP77< ESO7
-----END PRIVACY-ENHANCED MESSAGE-----